CHE (Chemed Corporation) Stock Financials & Earnings | Market Cap Arena

CHE (Chemed Corporation) Stock Financials & Earnings | Market Cap Arena

CHEChemed Corporation

Mkt Cap$6B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NYSE

Revenue (TTM)$2.5B

Net Income (TTM)$265M

EPS (TTM)$18.37

Free Cash Flow (TTM)$325M

Gross Margin31.1%

Op. Margin13.4%

Net Margin10.5%

FCF Margin12.9%

P/S Ratio (TTM)2.3x

P/E Ratio (TTM)21.6x

YoY Rev Growth+4.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$560M	$189M	$73M
Q2 23	$554M	$180M	$70M
Q3 23	$565M	$202M	$87M
Q4 23	$586M	$228M	$111M
Q1 24	$589M	$204M	$72M
Q2 24	$596M	$206M	$88M
Q3 24	$606M	$210M	$92M
Q4 24	$640M	$234M	$114M
Q1 25	$647M	$216M	$95M
Q2 25	$619M	$185M	$68M
Q3 25	$625M	$181M	$75M
Q4 25	$639M	$206M	$101M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	2.6x	23.9x
Q2 23	2.6x	25.2x
Q3 23	2.6x	23.4x
Q4 23	2.5x	21.0x
Q1 24	2.5x	20.2x
Q2 24	2.4x	19.0x
Q3 24	2.4x	18.9x
Q4 24	2.4x	18.9x
Q1 25	2.3x	18.5x
Q2 25	2.3x	19.7x
Q3 25	2.3x	20.5x
Q4 25	2.3x	21.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$60M	$43M
Q2 23	$132M	$116M
Q3 23	$29M	$17M
Q4 23	$109M	$97M
Q1 24	$85M	$72M
Q2 24	$78M	$66M
Q3 24	$91M	$77M
Q4 24	$165M	$152M
Q1 25	$33M	$19M
Q2 25	$139M	$123M
Q3 25	$83M	$66M
Q4 25	$134M	$117M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$17M
Q2 23	$16M
Q3 23	$12M
Q4 23	$12M
Q1 24	$12M
Q2 24	$11M
Q3 24	$14M
Q4 24	$13M
Q1 25	$13M
Q2 25	$16M
Q3 25	$17M
Q4 25	$16M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+5.6%	+10.5%
Q2 23	+4.2%	+10.2%
Q3 23	+7.2%	+7.2%
Q4 23	+7.2%	+2.0%
Q1 24	+5.2%	+6.1%
Q2 24	+7.6%	+4.8%
Q3 24	+7.4%	+7.6%
Q4 24	+9.2%	+10.9%
Q1 25	+9.8%	+6.8%
Q2 25	+3.8%	+8.5%
Q3 25	+3.1%	+7.0%
Q4 25	-0.1%	+2.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$8M	1.5%
Q2 23	$8M	1.5%
Q3 23	$5M	1.0%
Q4 23	$8M	1.3%
Q1 24	$9M	1.5%
Q2 24	$9M	1.5%
Q3 24	$6M	1.0%
Q4 24	$8M	1.3%
Q1 25	$9M	1.4%
Q2 25	$9M	1.5%
Q3 25	-$15M	-2.4%
Q4 25	$24M	3.7%

OpEx Breakdown

Quarter	G&A	SG&A
Q1 23	$100M	—
Q2 23	$93M	—
Q3 23	$100M	—
Q4 23	$100M	—
Q1 24	$116M	—
Q2 24	$100M	—
Q3 24	$102M	—
Q4 24	$104M	—
Q1 25	$106M	—
Q2 25	$99M	—
Q3 25	$106M	—
Q4 25	—	$106M

Revenue Segments

Quarter	Segment Roto Rooter	Segment Vitas
Q1 25	$249M	$416M
Q3 25	$226M	$421M
Q4 25	$232M	$430M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$58M	$0	$58M
Q2 23	$160M	$0	$160M
Q3 23	$173M	$0	$173M
Q4 23	$264M	$0	$264M
Q1 24	$313M	$0	$313M
Q2 24	$223M	$0	$223M
Q3 24	$238M	$0	$238M
Q4 24	$178M	$0	$178M
Q1 25	$174M	$0	$174M
Q2 25	$250M	$0	$250M
Q3 25	$130M	$0	$130M
Q4 25	$75M	$0	$75M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	15M	+0.4%
Q2 23	15M	+0.7%
Q3 23	15M	-0.1%
Q4 23	15M	+0.5%
Q1 24	15M	+0.5%
Q2 24	15M	-0.6%
Q3 24	15M	-1.1%
Q4 24	15M	-0.6%
Q1 25	15M	-1.5%
Q2 25	15M	-1.1%
Q3 25	15M	-0.5%
Q4 25	14M	-3.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$103K	14K
FY 15	$107K	14K
FY 16	$108K	15K
FY 17	$113K	15K
FY 18	$113K	16K
FY 19	$116K	17K
FY 20	$134K	16K
FY 21	$151K	14K
FY 22	$151K	14K
FY 23	$150K	15K
FY 24	$161K	15K
FY 25	$168K	15K